image
Blueprint Medicines Corporation BPMC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 92.02
-4.71 %
$ 5.88 B
Market Cap
-86.0
P/E
INCOME STATEMENT
509 M REVENUE
104.04%
Growth Rates
1Year 104.04%
3Years 41.37%
5Years 50.22%
7Years 57.22%
10Years 0.00%
-212 M OPERATING INCOME
56.39%
Growth Rates
1Year 56.39%
3Years 31.11%
5Years 10.37%
7Years -5.12%
10Years -18.20%
-67.1 M NET INCOME
86.77%
Growth Rates
1Year 86.77%
3Years 52.95%
5Years 28.04%
7Years 10.70%
10Years -5.23%
EFFICIENCY
Earnings Waterfall Blueprint Medicines Corporation
image
Revenue 509 M
Cost Of Revenue 20.2 M
Gross Profit 489 M
Operating Expenses 701 M
Operating Income -212 M
Other Expenses -145 M
Net Income -67.1 M

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 508.8 249.4 204.0 180.1 793.7 66.5 44.5 21.4 27.8 11.4 0 0
GROSS PROFIT
Cost Of Revenue 20.2 12.8 17.8 17.9 0.4 0 243.6 144.7 81.1 48.6 31.8 15.9
Gross Profit 488.7 236.6 186.2 162.1 793.3 66.5 (199.1) (123.3) (53.4) (37.2) (31.8) (15.9)
OPERATING INCOME
Operating Expenses 700.7 722.9 723.7 804.1 484.6 427.8 291.5 172.7 100.3 63.0 39.7 21.0
Selling, General and Administrative Expenses 359.3 295.1 237.4 195.3 157.7 96.4 47.9 28.0 19.2 14.5 7.9 5.1
Research and Development Expenses 341.4 427.7 477.4 601.0 326.9 331.4 243.6 144.7 81.1 48.6 31.8 15.9
Operating Income (212.0) (486.3) (549.3) (648.5) 302.1 (366.6) (247.0) (149.5) (73.6) (53.0) (39.8) (20.8)
PRE-TAX INCOME
Interest Income Expense 68.8 0 16.8 0 0 13.7 73 K 0.2 0.5 0.7 0.5 0.1
Total Other Income 146.2 (19.7) (14.8) 0.9 6.2 13.6 10.4 3.1 82 K (1.1) (0.6) 88 K
Pre-Tax Income (65.9) (506.0) (552.3) (641.1) 314.9 (347.7) (236.6) (148.1) (72.5) (52.8) (40.3) (20.9)
NET INCOME
Tax Provision 1.2 1.0 5.2 3.0 1.1 (19.0) 10.5 2.0 (0.6) (0.7) 0.4 0.4
Net Income (67.1) (507.0) (557.5) (644.1) 313.9 (328.7) (236.6) (148.1) (72.5) (52.8) (40.3) (20.9)
EPS 1.07 8.37 9.35 11 5.76 6.87 5.39 3.92 2.64 2.89 3.08 1.6